AstraZeneca unveils $50 billion US investment as pharma tariff threat looms – Reuters
- AstraZeneca unveils $50 billion US investment as pharma tariff threat looms Reuters
- AstraZeneca to Invest $50 Billion in U.S. by 2030 with Manufacturing Projects in Virginia geneonline.com
- AstraZeneca’s $50 Billion U.S. Bet: A Strategic Play in a Tariff-Driven Pharma Landscape AInvest
- Biopharmaceutical company announces multi-billion dollar plant in Virginia WWBT
- Pharmaceutical company selects Virginia for multi-billion-dollar manufacturing center WSLS